Oral formulation for dexlansoprazole

Details for Australian Patent Application No. 2010321874 (hide)

Owner Handa Pharmaceuticals, LLC

Inventors Shen, Zhiqun; Zhang, Yu; Fu, Enjun; He, Min Michael; Liu, Fang-Yu

Agent Allens Patent & Trade Mark Attorneys

Pub. Number AU-A-2010321874

PCT Pub. Number WO2011/063150

Priority 61/263,274 20.11.09 US

Filing date 18 November 2010

Wipo publication date 26 May 2011

International Classifications

A61K 9/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/44 - Non-condensed pyridines

A61K 31/4439

A61P 3/00 Drugs for disorders of the metabolism

A61P 3/04 Drugs for disorders of the metabolism

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/063150 Priority application(s): WO2011/063150

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010321880-Acid salt forms of polymer-drug conjugates and alkoxylation methods

2010321872-Method and apparatus for injection of CO2 or stack gasses to increase algal biomass production